跳转至内容
Merck
CN
所有图片(1)

文件

ISEQ00010

Millipore

Immobilon® -PSQ PVDF Membrane

1 roll, 27 cm x 3.75 m, 0.2 µm pore size, transfer membrane for Western blotting

登录查看公司和协议定价
所有图片(1)
别名:
Western blotting membrane, blotting membrane, transfer membrane
UNSPSC代码:
41105339
eCl@ss:
32031602
NACRES:
NB.23

product name

Immobilon®-PSQ PVDF膜, 1 roll, 27 cm x 3.75 m, 0.2 µm pore size, Hydrophobic PVDF Transfer Membrane for western blotting.

物料

PVDF membrane
plain filter
white filter

质量水平

400

特点

hydrophobic

制造商/商品名称

Immobilon®

技术

dot blot: suitable
western blot: suitable

过滤器长度 × 宽度

27 cm × 3.75 m

孔径

0.2 μm pore size

容量

262 μg/cm2 adsorption capacity (insulin)
 340 μg/cm2 adsorption capacity (BSA)
 448 μg/cm2 adsorption capacity (goat IgG)

相容性

for use with Amido black
for use with CPTS
for use with Colloidal gold
for use with Coomassie brilliant blue
for use with India ink
for use with Ponceau-S red
for use with Sypro<TMSYMBOL></TMSYMBOL> ruby
for use with Toluidine blue
for use with Transillumination

检测方法

chemiluminescent
colorimetric
radioactive

运输

ambient

相关类别

一般描述

Immobilon®-PSQ膜是由聚偏氟乙烯(PVDF)制成的0.2 μm微孔膜。该产品是为了最大化蛋白质结合而开发的。Immobilon®-PSQ膜推荐用于电泳凝胶电泳蛋白（或纯化蛋白样品的点结合）后的直接蛋白测序和免疫检测，特别是分子量小于20,000的蛋白。该滤膜兼容储水罐和半干法电印迹系统。

应用

Immobilon®-PSQ PVDF膜已用于蛋白质印迹分析。

特点和优势

Immobilon®-PSQ膜：
  • 0.2 μm孔径和大内部结构
  • 蛋白质吸附和测序产量高于其他膜
  • 防止低分子量蛋白质的吹穿

法律信息

Immobilon is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Bing Yan et al.
Theranostics, 10(15), 6728-6742 (2020-06-20)
Rational: Ischemic injury of the skeletal muscle remains a serious clinical problem and currently there is no effective therapy. The aim of the present study is to determine whether human umbilical cord mesenchymal stem cells- derived exosomes (UMSC-Exo) could repair
Chenggong Sun et al.
Journal of hematology & oncology, 13(1), 9-9 (2020-02-02)
PARP inhibitors have been the most promising target drugs with widely proven benefits among ovarian cancer patients. Although platinum-response, HR-related genes, or HRD genomic scar detection are acceptably used in assessment of Olaparib response, there are still evident limitations in
Jingshu Tang et al.
Brain research bulletin, 170, 1-10 (2021-02-07)
Traumatic brain injury (TBI) is the major cause of disability and mortality among young people and is associated with neurodegenerative diseases. However, the available clinical options have limited effectiveness. Here, we investigated the neuroprotective effect of Hemocoagulase Agkistrodon (HCA), a
Chenshuo Luo et al.
Journal of oncology, 2020, 3676751-3676751 (2020-05-16)
To verify and evaluate the value of CD40 as a noninvasive biomarker of cisplatin-resistant bladder cancer, we studied the expression of CD40 and the correlation between nucleophosmin (NPM1) and CD40 in cisplatin-resistant bladder cancer. Three cisplatin-resistant bladder cancer cell lines
Carey Wilson et al.
Neuropharmacology, 168, 107998-107998 (2020-02-18)
Traditional monoaminergic treatments of depression frequently exhibit suboptimal tolerability and effectiveness. The 'short' (s) allele variant of 5-HTTLPR is known to compromise transcriptional efficacy of the serotonin transporter (5-HTT) and can reduce treatment response to traditional antidepressants (e.g. selective serotonin
查看所有相关文献

实验方案

Stripping and Reprobing Western Blotting Membranes

This page shows and discusses three protocols for stripping and reprobing a western blot membrane.

免疫印迹膜剥离和再生检测

本页内容介绍和讨论了三种免疫印迹膜剥离和重新检测的方案。

WB检测样本前处理：细胞裂解和蛋白提取

Western blotting前用于培养组织和细胞的细胞裂解和有效蛋白提取的样品制备实验方案。

Cell Lysis and Protein Extraction for Western Blotting

Protocol for sample preparation for cell lysis and efficient protein extraction from cultured tissues and cells for subsequent Western blotting.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门